A latter aspect is supported by the findings of another study which demonstrated that the analysis of DMD mRNA expression from skeletal muscle but not from lymphocytes led to the identification of a novel nonsense mutation in a carrier of dystrophinopathy [52]. The gene discussed is DMD; the disease is neuromuscular disease caused by qualitative or quantitative defects of dystrophin.